BioPlus Acquisition Corp.

NASDAQ: BIOS · Real-Time Price · USD
10.79
-0.01 (-0.09%)
At close: Oct 06, 2023, 9:46 PM

BioPlus Acquisition Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Net Income
2M -152.94
Depreciation & Amortization
n/a n/a
Stock-Based Compensation
n/a n/a
Other Working Capital
n/a n/a
Other Non-Cash Items
-3.17M -691.35
Deferred Income Tax
n/a n/a
Change in Working Capital
479.73K n/a
Operating Cash Flow
-691.47K -844.3
Capital Expenditures
n/a n/a
Cash Acquisitions
n/a n/a
Purchase of Investments
n/a n/a
Sales Maturities Of Investments
n/a n/a
Other Investing Acitivies
n/a -255.93K
Investing Cash Flow
n/a -255.93K
Debt Repayment
n/a n/a
Common Stock Repurchased
n/a n/a
Dividend Paid
n/a n/a
Other Financial Acitivies
196.22K 257.46K
Financial Cash Flow
196.22K 257.46K
Net Cash Flow
-495.24K 692.70
Free Cash Flow
-691.47K -844.3